Who has invested in Complement Therapeutics?

BioGeneration Ventures (BGV), Forbion are named among the investors backing Complement Therapeutics.

Complement Therapeutics Funding: $5.3M Raised, Seed (2021)

Complement Therapeutics funding overview

Complement Therapeutics has raised $5.3M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Seed announced in January 2021. The round record for Complement Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include BioGeneration Ventures (BGV), Forbion. 2 distinct backers are named across the disclosed rounds.

Complement Therapeutics at a glance

Total raised: $5.3M
Latest round: Seed
Latest round date: January 2021
Notable investors: BioGeneration Ventures (BGV), Forbion

Frequently asked about Complement Therapeutics funding

How much has Complement Therapeutics raised?: Complement Therapeutics has raised $5.3M in total disclosed funding across the rounds on record.
Who has invested in Complement Therapeutics?: BioGeneration Ventures (BGV), Forbion are named among the investors backing Complement Therapeutics.
What was the latest Complement Therapeutics funding round?: The most recent disclosed round is a Seed, announced in January 2021.
Where is Complement Therapeutics based?: No headquarters location is disclosed for Complement Therapeutics.
When did Complement Therapeutics last raise?: The last disclosed Complement Therapeutics round closed in January 2021 at Seed.

Complement Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Complement Therapeutics Funding: $5.3M Raised, Seed (2021)

Complement Therapeutics funding overview

Complement Therapeutics at a glance

Frequently asked about Complement Therapeutics funding

Companies related to Complement Therapeutics (32)

Browse related funding lists (4)